Le Lézard
Classified in: Health, Business
Subjects: LAW, POL

U.S. Supreme Court Upholds Subsidies and Employer Mandate

KANSAS CITY, Mo., June 25, 2015 /PRNewswire/ -- Today's U.S. Supreme Court decision to allow subsidies for lower-income taxpayers buying health insurance through the federal marketplace also reinforces the enforceability of the employer mandate, said Lockton, the world's largest privately held independent insurance broker.

Lockton logo.

In an important Alert, Lockton explains the implications of the Supreme Court ruling.

"The Court has once again rescued a significant piece of the Affordable Care Act (ACA)," said Mark Holloway, Senior Vice President, Director, Compliance Services, Lockton Benefit Group. "Today's decision removes the uncertainty surrounding the fate of the employer mandate in the 34 states depending on the federally-operated marketplace for employers doing business in one or more of those states. The employer mandate is alive and well."

But even with this latest decision, Holloway said litigation will continue for the foreseeable future. For example, the U.S. House of Representatives is suing the President in federal court, asserting the delay of the employer mandate from 2014 to 2015 was an abuse of executive power under the U.S. Constitution.

In addition, there is another subsidy-related lawsuit working its way through a federal court. In that case, plaintiffs are challenging federal payments made to insurers to shrink deductibles and other cost-sharing aspects of health insurance coverage sold through the online public marketplaces. The plaintiffs argue that Congress did not appropriate money for those payments.

"Regardless of what comes next, this decision impacts many of our 41,000 clients who have been working hard over the last five years to meet the health reform law's employer mandate," said Bob Reiff, President ? Lockton Benefit Group. "As always, we will continue to partner with our clients to navigate the dynamic, twisting and turning road that is the Affordable Care Act."

For more information and Lockton's full reaction to the Court's decision, please read the Alert.

About Lockton

More than 5,300 professionals at Lockton provide 41,000 clients around the world with risk management, insurance, and employee benefits consulting services that improve their businesses. From its founding in 1966 in Kansas City, Missouri, Lockton has attracted entrepreneurial professionals who have driven its growth to become the largest privately held, independent insurance broker in the world and 10th largest overall. Independent researcher Greenwich Associates has awarded Lockton its Service Excellence Award for risk management for large companies. For six consecutive years, Business Insurance has recognized Lockton as a "Best Place to Work in Insurance." To see the latest insights from Lockton's employee benefits experts, check the Lockton Health Reform Blog, the Lockton Health Risk Solutions Blog, or the Lockton HR Technology Blog.

Logo - http://photos.prnewswire.com/prnh/20090415/CG99351LOGO


SOURCE Lockton

These press releases may also interest you

at 07:33
NORWOOD, MA--(Marketwired - October 17, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases,...

at 07:30
CAMBRIDGE, Mass., Oct. 17, 2017 /PRNewswire/ -- Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced collaborations with the Icahn School of Medicine at...

at 07:30
BRIDGEWATER, N.J. and HAYWARD, Calif., Oct. 17, 2017 /PRNewswire/ --  Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that they have entered into a definitive business combination in an all-stock transaction. As...

at 07:30
MARIETTA, Ga., Oct. 17, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected...

at 07:30
SACRAMENTO, Calif., Oct. 17, 2017 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and...

at 07:30
Narrated presentation of results available on ProMIS website TSX: PMN TORONTO and CAMBRIDGE, MA, Oct. 17, 2017 /CNW/ - ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for...

News published on 25 june 2015 at 12:09 and distributed by: